CWEB Charlotte's Web | 5/18/2022 | Reiterated by | Cantor Fitzgerald | | Hold | C$0.70 | N/A | |
VLTA Volta | 5/18/2022 | Target Lowered by | Cantor Fitzgerald | Analyst A. Sheppard | | $8.00 -> $6.00 | High | |
AGTC Applied Genetic Technologies | 5/17/2022 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | | Low | |
SPRO Spero Therapeutics | 5/17/2022 | Target Lowered by | Cantor Fitzgerald | | | $27.00 -> $5.00 | High | |
AYTU Aytu BioPharma | 5/17/2022 | Target Lowered by | Cantor Fitzgerald | | | $11.00 -> $5.00 | High | |
ELDN Eledon Pharmaceuticals | 5/13/2022 | Initiated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight | $25.00 -> $15.00 | Low | |
FBIO Fortress Biotech | 5/13/2022 | Reiterated by | Cantor Fitzgerald | Analyst Jennifer Kim | Buy | $6.00 | High | |
PSTX Poseida Therapeutics | 5/13/2022 | Initiated by | Cantor Fitzgerald | Analyst Jennifer Kim | Buy | $24.00 | Medium | |
VERU Veru | 5/13/2022 | Reiterated by | Cantor Fitzgerald | Analyst B. Folkes | Overweight | | High | |
SMRT SmartRent | 5/12/2022 | Upgraded by | Cantor Fitzgerald | Analyst B. Sherlund | Neutral -> Overweight | | Low | |
|
ACB Aurora Cannabis | 5/13/2022 | Target Lowered by | Cantor Fitzgerald | | | C$7.60 -> C$3.90 | High | |
ASND Ascendis Pharma A/S | 5/12/2022 | Target Lowered by | Cantor Fitzgerald | Analyst L. Watsek | | $230.00 -> $180.00 | High | |
ETNB 89bio | 5/12/2022 | Target Lowered by | Cantor Fitzgerald | | | $41.00 -> $27.00 | High | |
TGTX TG Therapeutics | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | High | |
TCRT Alaunos Therapeutics | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | Low | |
RGLS Regulus Therapeutics | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight | | Low | |
PSTX Poseida Therapeutics | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst J. Kim | Overweight | | Low | |
PRQR ProQR Therapeutics | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst J. Kim | Overweight | | Low | |
IMNM Immunome | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight | | High | |
HARP Harpoon Therapeutics | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst J. Kim | Overweight | | Medium | |
GOSS Gossamer Bio | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst O. Brayer | Overweight | | High | |
FMTX Forma Therapeutics | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | High | |
EQ Equillium | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | Medium | |
BHVN Biohaven Pharmaceutical | 5/11/2022 | Downgraded by | Cantor Fitzgerald | Analyst C. Duncan | Overweight -> Neutral | | Low | |
BCRX BioCryst Pharmaceuticals | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight | | Low | |
ARCT Arcturus Therapeutics | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight | | High | |
ALLK Allakos | 5/9/2022 | Reiterated by | Cantor Fitzgerald | Analyst J. Kim | Overweight | | High | |
GRAY Graybug Vision | 5/11/2022 | Target Lowered by | Cantor Fitzgerald | Analyst Jennifer Kim | | $4.00 -> $2.50 | Medium | |
INO Inovio Pharmaceuticals | 5/11/2022 | Target Lowered by | Cantor Fitzgerald | | | $6.00 -> $3.00 | High | |
SFT Shift Technologies | 5/11/2022 | Target Lowered by | Cantor Fitzgerald | | | $8.00 -> $4.00 | High | |
HRTX Heron Therapeutics | 5/10/2022 | Target Lowered by | Cantor Fitzgerald | Analyst B. Folkes | | $20.00 -> $12.00 | High | |
ARDX Ardelyx | 5/6/2022 | Downgraded by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Neutral | $7.00 -> $1.00 | Medium | |
ETTX Entasis Therapeutics | 5/6/2022 | Downgraded by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Neutral | | Medium | |
TXMD TherapeuticsMD | 5/6/2022 | Downgraded by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Neutral | | High | |
PACB Pacific Biosciences of California | 5/5/2022 | Target Lowered by | Cantor Fitzgerald | Analyst R. Osborn | | $23.00 -> $19.00 | High | |
SMTI Sanara MedTech | 5/2/2022 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | | Low | |
SPT Sprout Social | 5/4/2022 | Target Lowered by | Cantor Fitzgerald | | | $99.00 -> $80.00 | High | |
AUPH Aurinia Pharmaceuticals | 4/28/2022 | Reiterated by | Cantor Fitzgerald | Analyst O. Brayer | Overweight | | High | |
EBS Emergent BioSolutions | 4/29/2022 | Downgraded by | Cantor Fitzgerald | Analyst B. Folkes | Overweight -> Neutral | | Low | |
ROIV Roivant Sciences | 4/29/2022 | Initiated by | Cantor Fitzgerald | | Overweight | $15.00 | High | |
GBT Global Blood Therapeutics | 4/28/2022 | Initiated by | Cantor Fitzgerald | Analyst Li Watsek | Buy | $75.00 | High | |
SIOX Sio Gene Therapies | 4/28/2022 | Downgraded by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Neutral | $0.80 | High | |
EVGO EVgo | 4/28/2022 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $14.00 | Medium | |
SPNE SeaSpine | 4/22/2022 | Target Lowered by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | $27.00 -> $21.00 | Medium | |
MRNS Marinus Pharmaceuticals | 4/20/2022 | Target Raised by | Cantor Fitzgerald | Analyst C. Duncan | | $25.00 -> $28.00 | High | |
PRQR ProQR Therapeutics | 4/19/2022 | Target Lowered by | Cantor Fitzgerald | Analyst B. Cheng | | $6.00 -> $3.50 | Low | |
SPNE SeaSpine | 4/12/2022 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | | N/A | |
DRTS Alpha Tau Medical | 4/14/2022 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $20.00 | High | |
HRMY Harmony Biosciences | 4/14/2022 | Initiated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | $63.00 | Low | |
BCYC Bicycle Therapeutics | 4/7/2022 | Initiated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | $100.00 -> $80.00 | High | |
|
APTX Aptinyx | 4/8/2022 | Target Lowered by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | $11.00 -> $5.00 | High | |
PAGS PagSeguro Digital | 4/8/2022 | Initiated by | Cantor Fitzgerald | | Overweight | $25.00 | Low | |
STNE StoneCo | 4/8/2022 | Initiated by | Cantor Fitzgerald | Analyst J. Siegler | Overweight | $15.00 | Medium | |
SIBN SI-BONE | 4/7/2022 | Initiated by | Cantor Fitzgerald | | Overweight | $34.00 | Medium | |
TLRY Tilray | 4/7/2022 | Target Raised by | Cantor Fitzgerald | | Neutral | $6.90 -> $8.40 | High | |
ISPO Inspirato | 4/7/2022 | Initiated by | Cantor Fitzgerald | Analyst B. Sherlund | Neutral | $9.00 | Low | |
JOBY Joby Aviation | 4/5/2022 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $10.00 | High | |
CRIS Curis | 4/5/2022 | Target Lowered by | Cantor Fitzgerald | Analyst L. Watsek | | $12.00 -> $4.00 | High | |
XNCR Xencor | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight | | N/A | |
VSTM Verastem | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight | | N/A | |
THRX Theseus Pharmaceuticals | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | | N/A | |
TGTX TG Therapeutics | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst B. Cheng | Overweight | | N/A | |
TCRT Alaunos Therapeutics | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst B. Cheng | Overweight | | N/A | |
APS Aptose Biosciences | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | N/A | |
STOK Stoke Therapeutics | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | N/A | |
RCUS Arcus Biosciences | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | N/A | |
PTCT PTC Therapeutics | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $64.00 -> $63.00 | N/A | |
PRVB Provention Bio | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | N/A | |
NEXI NexImmune | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | N/A | |
MRNS Marinus Pharmaceuticals | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | N/A | |
LBPH Longboard Pharmaceuticals | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | N/A | |
GBT Global Blood Therapeutics | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | N/A | |
FMTX Forma Therapeutics | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst B. Cheng | Overweight | | N/A | |
FATE Fate Therapeutics | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | N/A | |
CRIS Curis | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | N/A | |
CBAY CymaBay Therapeutics | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | | N/A | |
BCYC Bicycle Therapeutics | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | $100.00 -> $80.00 | N/A | |
AUPH Aurinia Pharmaceuticals | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | | N/A | |
ASND Ascendis Pharma A/S | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | N/A | |
ARWR Arrowhead Pharmaceuticals | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | N/A | |
ARVN Arvinas | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | N/A | |
APTO Aptose Biosciences | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | N/A | |
ALXO ALX Oncology | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | N/A | |
ALGS Aligos Therapeutics | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | N/A | |
SPT Sprout Social | 4/5/2022 | Initiated by | Cantor Fitzgerald | | Overweight | $99.00 | N/A | |
SPPI Spectrum Pharmaceuticals | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst A. Young | Neutral | | High | |
RAPT RAPT Therapeutics | 4/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst A. Young | Overweight | | High | |
AKBA Akebia Therapeutics | 4/1/2022 | Downgraded by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight -> Neutral | | Low | |
CRNX Crinetics Pharmaceuticals | 3/31/2022 | Reiterated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | High | |
MIGI Mawson Infrastructure Group | 3/30/2022 | Initiated by | Cantor Fitzgerald | Analyst M. Colonnese | Overweight | $12.00 | Low | |
NKTX Nkarta | 3/29/2022 | Reiterated by | Cantor Fitzgerald | Analyst A. Young | Overweight | | High | |
ELDN Eledon Pharmaceuticals | 3/29/2022 | Reiterated by | Cantor Fitzgerald | Analyst A. Young | Overweight | | Low | |
PWSC PowerSchool | 3/29/2022 | Initiated by | Cantor Fitzgerald | | Overweight | $20.00 | High | |
TWOU 2U | 3/29/2022 | Initiated by | Cantor Fitzgerald | | Neutral | $12.00 | High | |
NRDY Nerdy | 3/29/2022 | Initiated by | Cantor Fitzgerald | | Overweight | $7.00 | High | |
UDMY Udemy | 3/29/2022 | Initiated by | Cantor Fitzgerald | | Overweight | $22.00 | Low | |
COUR Coursera | 3/29/2022 | Initiated by | Cantor Fitzgerald | | Overweight | $30.00 | High | |
GRAY Graybug Vision | 3/25/2022 | Reiterated by | Cantor Fitzgerald | Analyst Jennifer Kim | Buy | $4.00 | Low | |
XELA Exela Technologies | 3/24/2022 | Target Lowered by | Cantor Fitzgerald | | Overweight | $4.00 -> $2.00 | Medium | |
VYNE VYNE Therapeutics | 3/18/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | |
AYRWF Ayr Wellness | 3/18/2022 | Target Lowered by | Cantor Fitzgerald | | Neutral | $17.50 -> $13.30 | Medium | |
HITI High Tide | 3/18/2022 | Target Lowered by | Cantor Fitzgerald | | Neutral | $7.25 -> $7.00 | High | |
GRAY Graybug Vision | 3/17/2022 | Target Lowered by | Cantor Fitzgerald | | Overweight | $6.00 -> $4.00 | High | |
TRSSF TerrAscend | 3/17/2022 | Target Raised by | Cantor Fitzgerald | | Overweight | $7.65 -> $7.90 | High | |
OPNT Opiant Pharmaceuticals | 3/16/2022 | Reiterated by | Cantor Fitzgerald | Analyst B. Folkes | Overweight | | High | |
NEXI NexImmune | 3/15/2022 | Reiterated by | Cantor Fitzgerald | Analyst A. Young | Overweight | | High | |
NHWK NightHawk Biosciences | 3/15/2022 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | | High | |
ANIP ANI Pharmaceuticals | 3/16/2022 | Reiterated by | Cantor Fitzgerald | Analyst B. Folkes | Neutral | | Medium | |
ALXO ALX Oncology | 3/14/2022 | Target Lowered by | Cantor Fitzgerald | | | $103.00 -> $60.00 | High | |
ACRX AcelRx Pharmaceuticals | 3/11/2022 | Reiterated by | Cantor Fitzgerald | Analyst B. Folkes | Overweight | | High | |
FMTX Forma Therapeutics | 3/11/2022 | Target Lowered by | Cantor Fitzgerald | Analyst A. Young | | $68.00 -> $46.00 | High | |
ML MoneyLion | 3/11/2022 | Target Lowered by | Cantor Fitzgerald | Analyst J. Siegler | | $8.00 -> $5.00 | High | |
ACAD ACADIA Pharmaceuticals | 3/10/2022 | Target Raised by | Cantor Fitzgerald | | Overweight | $32.00 -> $37.00 | High | |
IREN Iris Energy | 3/9/2022 | Target Lowered by | Cantor Fitzgerald | Analyst M. Colonnese | | $25.00 -> $22.00 | High | |
MVIS MicroVision | 3/7/2022 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral | $5.00 | High | |
VFF Village Farms International | 3/7/2022 | Target Lowered by | Cantor Fitzgerald | | Overweight | $12.75 -> $9.30 | High | |
EYPT EyePoint Pharmaceuticals | 3/4/2022 | Reiterated by | Cantor Fitzgerald | Analyst J. Kim | Overweight | | High | |
EOLS Evolus | 3/4/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | $20.00 | High | |
TLRY Tilray Brands | 3/4/2022 | Reiterated by | Cantor Fitzgerald | | Neutral | C$9.00 | N/A | |
HEXO HEXO | 3/4/2022 | Target Lowered by | Cantor Fitzgerald | | Neutral | $1.20 -> $0.90 | High | |
JAZZ Jazz Pharmaceuticals | 3/2/2022 | Reiterated by | Cantor Fitzgerald | Analyst B. Folkes | Overweight | | Low | |
AMRN Amarin | 3/2/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Medium | |
CRIS Curis | 3/2/2022 | Target Lowered by | Cantor Fitzgerald | | | $24.00 -> $12.00 | High | |
CLDX Celldex Therapeutics | 3/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | | Low | |
ARDX Ardelyx | 3/1/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | High | |
HRTX Heron Therapeutics | 3/1/2022 | Target Lowered by | Cantor Fitzgerald | Analyst B. Folkes | Overweight | $26.00 -> $20.00 | High | |
ARCT Arcturus Therapeutics | 3/1/2022 | Target Lowered by | Cantor Fitzgerald | | | $93.00 -> $86.00 | Low | |
HEPA Hepion Pharmaceuticals | 2/28/2022 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $3.50 | High | |
JSPR Jasper Therapeutics | 2/28/2022 | Initiated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight | $10.00 | Low | |
ACRS Aclaris Therapeutics | 2/25/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | High | |
GDYN Grid Dynamics | 2/25/2022 | Target Lowered by | Cantor Fitzgerald | | | $40.00 -> $25.00 | High | |
LTCH Latch | 2/25/2022 | Downgraded by | Cantor Fitzgerald | Analyst B. Sherlund | Overweight -> Neutral | $16.00 -> $5.00 | High | |
GTBIF Green Thumb Industries | 2/25/2022 | Target Lowered by | Cantor Fitzgerald | | Overweight | $54.00 -> $41.00 | High | |
MAPS WM Technology | 2/24/2022 | Target Raised by | Cantor Fitzgerald | | Overweight | $6.25 -> $7.65 | High | |
VNRX VolitionRx | 2/18/2022 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | | N/A | |
ARQT Arcutis Biotherapeutics | 2/23/2022 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | High | |
AFMD Affimed | 2/23/2022 | Initiated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | $12.00 | High | |
HITI High Tide | 2/22/2022 | Target Lowered by | Cantor Fitzgerald | | Neutral | $7.75 -> $7.25 | High | |
PSTX Poseida Therapeutics | 2/18/2022 | Initiated by | Cantor Fitzgerald | Analyst Brian Cheng | Buy | $24.00 | High | |
CGC Canopy Growth | 2/18/2022 | Target Raised by | Cantor Fitzgerald | Analyst Pablo Zuanic | Neutral | C$9.60 -> C$11.00 | High | |
IREN Iris Energy | 2/18/2022 | Initiated by | Cantor Fitzgerald | Analyst M. Colonnese | Overweight | $25.00 | Low | |
VTVT vTv Therapeutics | 2/18/2022 | Initiated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | $5.00 | High | |
ORMP Oramed Pharmaceuticals | 2/18/2022 | Initiated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | $20.00 | Low | |
CYTK Cytokinetics | 2/17/2022 | Target Lowered by | Cantor Fitzgerald | Analyst Charles Duncan | | $57.00 -> $53.00 | High | |
PAVM PAVmed | 2/12/2022 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | | High | |
COLL Collegium Pharmaceutical | 2/15/2022 | Upgraded by | Cantor Fitzgerald | Analyst B. Folkes | Neutral -> Overweight | $18.00 -> $26.00 | High | |
NVAX Novavax | 2/14/2022 | Target Lowered by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | $282.00 -> $174.00 | High | |
ACB Aurora Cannabis | 2/11/2022 | Target Lowered by | Cantor Fitzgerald | | | C$10.75 -> C$7.60 | High | |
IDEX Ideanomics | 2/11/2022 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $3.00 | High | |
LUCD Lucid Diagnostics | 2/4/2022 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | | Medium | |
CGC Canopy Growth | 1/28/2022 | Target Lowered by | Cantor Fitzgerald | Analyst Pablo Zuanic | | C$16.30 -> C$9.60 | High | |
PACB Pacific Biosciences of California | 1/25/2022 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | | High | |
ALKS Alkermes | 1/27/2022 | Upgraded by | Cantor Fitzgerald | Analyst B. Folkes | Hold -> Overweight | $32.00 | High | |
CKPT Checkpoint Therapeutics | 1/26/2022 | Target Raised by | Cantor Fitzgerald | | | $16.00 -> $20.00 | Medium | |
MAPS WM Technology | 1/25/2022 | Target Lowered by | Cantor Fitzgerald | | Overweight | $11.00 -> $6.25 | High | |
EBS Emergent BioSolutions | 1/20/2022 | Target Raised by | Cantor Fitzgerald | | | $50.00 -> $55.00 | High | |
XGN Exagen | 1/14/2022 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | | High | |
OMER Omeros | 1/18/2022 | Target Lowered by | Cantor Fitzgerald | | | $34.00 -> $20.00 | High | |
REE REE Automotive | 1/14/2022 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $9.00 | High | |
FOLD Amicus Therapeutics | 1/13/2022 | Target Lowered by | Cantor Fitzgerald | | Overweight | $16.00 -> $15.00 | Medium | |
AWH Aspira Women's Health | 1/11/2022 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | | High | |
OGI OrganiGram | 1/12/2022 | Target Lowered by | Cantor Fitzgerald | | Overweight | $5.70 -> $5.30 | Medium | |
IMNM Immunome | 1/11/2022 | Target Lowered by | Cantor Fitzgerald | Analyst B. Cheng | | $35.00 -> $33.00 | High | |
AVPT AvePoint | 1/11/2022 | Initiated by | Cantor Fitzgerald | | Overweight | $10.00 | High | |
BNOX Bionomics | 1/10/2022 | Initiated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | Medium | |
CTGO Contango Ore | 1/7/2022 | Initiated by | Cantor Fitzgerald | | Overweight | $37.50 | Medium | |
PSTX Poseida Therapeutics | 1/7/2022 | Initiated by | Cantor Fitzgerald | Analyst Brian Cheng | Overweight | $24.00 | High | |
TLRY Tilray | 1/7/2022 | Target Lowered by | Cantor Fitzgerald | | Neutral | $11.80 -> $7.40 | Medium | |
ORTX Orchard Therapeutics | 12/30/2021 | Initiated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight | $12.00 -> $9.00 | High | |
BTX Brooklyn ImmunoTherapeutics | 12/29/2021 | Initiated by | Cantor Fitzgerald | | Overweight | $9.00 | N/A | |
NYXH Nyxoah | 12/21/2021 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | | N/A | |
VINC Vincerx | 12/23/2021 | Initiated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | $25.00 | High | |
OPAD Offerpad Solutions | 12/21/2021 | Initiated by | Cantor Fitzgerald | Analyst B. Sherlund | Overweight | $10.00 | High | |
CRDL Cardiol Therapeutics | 12/17/2021 | Initiated by | Cantor Fitzgerald | Analyst Charles Duncan | Buy | C$8.00 | N/A | |
CRDL Cardiol Therapeutics | 12/17/2021 | Initiated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | $8.00 | Medium | |
LVOX LiveVox | 12/15/2021 | Initiated by | Cantor Fitzgerald | | Overweight | $8.00 | High | |
FAF First American Financial | 12/15/2021 | Target Lowered by | Cantor Fitzgerald | | Overweight | $13.00 -> $10.40 | Medium | |
VLTA Volta | 12/14/2021 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $13.00 | High | |
XELA Exela Technologies | 12/10/2021 | Reiterated by | Cantor Fitzgerald | | Buy | | Low | |
HITI High Tide | 12/10/2021 | Target Lowered by | Cantor Fitzgerald | | Neutral | $8.75 -> $7.75 | Medium | |
TRSSF TerrAscend | 12/8/2021 | Target Raised by | Cantor Fitzgerald | | Overweight -> Overweight | $6.70 -> $7.65 | Medium | |
OGI OrganiGram | 12/8/2021 | Target Raised by | Cantor Fitzgerald | | Overweight | $5.50 -> $5.70 | Medium | |
RETA Reata Pharmaceuticals | 12/7/2021 | Target Lowered by | Cantor Fitzgerald | | Overweight -> Overweight | $230.00 -> $112.00 | High | |
ACAD ACADIA Pharmaceuticals | 12/7/2021 | Target Raised by | Cantor Fitzgerald | | Positive -> Overweight | $27.00 -> $31.00 | High | |
CRVS Corvus Pharmaceuticals | 12/3/2021 | Target Raised by | Cantor Fitzgerald | Analyst Li Watsek | Overweight -> Overweight | $5.00 -> $8.00 | High | |
SLS SELLAS Life Sciences Group | 12/3/2021 | Target Lowered by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | $18.00 -> $16.00 | High | |
AYRWF Ayr Wellness | 12/2/2021 | Target Lowered by | Cantor Fitzgerald | | Neutral | $22.60 -> $17.50 | Medium | |
FRX Fennec Pharmaceuticals | 11/30/2021 | Downgraded by | Cantor Fitzgerald | Analyst C. Duncan | Overweight -> Neutral | | N/A | |
OPTN OptiNose | 11/30/2021 | Reiterated by | Cantor Fitzgerald | Analyst B. Folkes | Overweight | | Low | |
FENC Fennec Pharmaceuticals | 11/30/2021 | Downgraded by | Cantor Fitzgerald | Analyst C. Duncan | Overweight -> Neutral | | High | |
SRRA Sierra Oncology | 11/30/2021 | Target Raised by | Cantor Fitzgerald | Analyst B. Cheng | Overweight | $33.00 -> $39.00 | Low | |
ACHR Archer Aviation | 11/30/2021 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $14.00 | Medium | |
FAF First American Financial | 11/23/2021 | Initiated by | Cantor Fitzgerald | | Overweight | | Low | |
MAPS WM Technology | 11/22/2021 | Initiated by | Cantor Fitzgerald | | Overweight | $11.00 | Medium | |
HITI High Tide | 11/22/2021 | Initiated by | Cantor Fitzgerald | | Neutral | $8.75 | Low | |
ML MoneyLion | 11/22/2021 | Initiated by | Cantor Fitzgerald | Analyst J. Siegler | Overweight | $8.00 | High | |
ASND Ascendis Pharma A/S | 11/18/2021 | Reiterated by | Cantor Fitzgerald | Analyst A. Young | Overweight | | Low | |
ABEO Abeona Therapeutics | 11/18/2021 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | | High | |
APS Aptose Biosciences | 11/17/2021 | Reiterated by | Cantor Fitzgerald | Analyst A. Young | Overweight | | N/A | |
APTO Aptose Biosciences | 11/17/2021 | Reiterated by | Cantor Fitzgerald | Analyst A. Young | Overweight | | Medium | |
RAPT RAPT Therapeutics | 11/16/2021 | Target Lowered by | Cantor Fitzgerald | Analyst A. Young | Overweight | $71.00 -> $58.00 | High | |
ARCT Arcturus Therapeutics | 11/16/2021 | Target Raised by | Cantor Fitzgerald | Analyst B. Cheng | Overweight | $85.00 -> $93.00 | Low | |
MNKD MannKind | 11/12/2021 | Reiterated by | Cantor Fitzgerald | Analyst B. Folkes | Overweight | | Medium | |
MBIO Mustang Bio | 11/15/2021 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | | Low | |
INVZ Innoviz Technologies | 11/11/2021 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | | Low | |
HGEN Humanigen | 11/15/2021 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | High | |
CRLBF Cresco Labs | 11/15/2021 | Target Raised by | Cantor Fitzgerald | Analyst Pablo Zuanic | Top Pick -> Overweight | $12.00 -> $19.00 | High | |
OTIC Otonomy | 11/11/2021 | Reiterated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | Medium | |
AZYO Aziyo Biologics | 11/11/2021 | Reiterated by | Cantor Fitzgerald | Analyst B. Folkes | Overweight | | Low | |
GPL Great Panther Mining | 11/12/2021 | Upgraded by | Cantor Fitzgerald | Analyst Matthew O'Keefe | Buy | | N/A | |
APTX Aptinyx | 11/10/2021 | Reiterated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | High | |
CWBR CohBar | 11/12/2021 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $2.50 | High | |
HYLN Hyliion | 11/11/2021 | Initiated by | Cantor Fitzgerald | Analyst J. Cohen | Overweight | $12.00 | High | |
GTBIF Green Thumb Industries | 11/11/2021 | Target Raised by | Cantor Fitzgerald | | Overweight | $38.00 -> $54.00 | High | |
BHVN Biohaven Pharmaceutical | 11/10/2021 | Target Raised by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight | $165.00 -> $177.00 | Medium | |
REGN Regeneron Pharmaceuticals | 11/10/2021 | Target Raised by | Cantor Fitzgerald | Analyst Alethia Young | Positive -> Overweight | $700.00 -> $760.00 | Medium | |
STOK Stoke Therapeutics | 11/9/2021 | Reiterated by | Cantor Fitzgerald | Analyst A. Young | Overweight | | High | |
AXSM Axsome Therapeutics | 11/9/2021 | Reiterated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | High | |
CMPS COMPASS Pathways | 11/9/2021 | Target Raised by | Cantor Fitzgerald | | Positive -> Overweight | $71.00 -> $82.00 | High | |
VFF Village Farms International | 11/9/2021 | Upgraded by | Cantor Fitzgerald | | Neutral -> Overweight | $11.50 -> $12.75 | High | |
MDRX Allscripts Healthcare Solutions | 11/5/2021 | Reiterated by | Cantor Fitzgerald | Analyst S. Halper | Neutral | | Medium | |
ADMA ADMA Biologics | 11/8/2021 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $4.50 | Medium | |
LUCD Lucid Diagnostics | 11/8/2021 | Initiated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | $21.00 | High | |
PFE Pfizer | 11/5/2021 | Reiterated by | Cantor Fitzgerald | Analyst Louise Chen | Buy | $60.00 | Low | |
SRPT Sarepta Therapeutics | 11/4/2021 | Target Raised by | Cantor Fitzgerald | | Overweight | $128.00 -> $140.00 | High | |
DRRX DURECT | 11/3/2021 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | | Low | |
AYRWF Ayr Wellness | 11/3/2021 | Target Lowered by | Cantor Fitzgerald | | Neutral | $33.50 -> $22.60 | High | |
CRLBF Cresco Labs | 11/3/2021 | Target Lowered by | Cantor Fitzgerald | Analyst Pablo Zuanic | Overweight | $12.65 -> $12.00 | Low | |
GTBIF Green Thumb Industries | 11/3/2021 | Target Lowered by | Cantor Fitzgerald | Analyst Pablo Zuanic | Overweight | $46.00 -> $38.00 | Low | |
TRSSF TerrAscend | 11/3/2021 | Target Lowered by | Cantor Fitzgerald | | Overweight | $8.65 -> $6.70 | Low | |
CLNN Clene | 11/3/2021 | Target Lowered by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | $24.00 -> $15.00 | Medium | |
NBIX Neurocrine Biosciences | 11/2/2021 | Target Raised by | Cantor Fitzgerald | | Overweight | $117.00 -> $123.00 | High | |
VXRT Vaxart | 11/2/2021 | Initiated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | $15.00 | High | |
OCGN Ocugen | 11/2/2021 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Neutral | $4.00 | High | |
THRX Theseus Pharmaceuticals | 11/1/2021 | Initiated by | Cantor Fitzgerald | Analyst A. Young | Overweight | $25.00 | Medium | |
TLRY Tilray | 11/1/2021 | Downgraded by | Cantor Fitzgerald | | Overweight -> Neutral | $18.00 -> $11.80 | High | |
ALNY Alnylam Pharmaceuticals | 10/29/2021 | Target Raised by | Cantor Fitzgerald | | Overweight | $202.00 -> $275.00 | Low | |
IMNM Immunome | 10/29/2021 | Initiated by | Cantor Fitzgerald | Analyst B. Cheng | Overweight | $35.00 | Low | |
TDOC Teladoc Health | 10/28/2021 | Target Lowered by | Cantor Fitzgerald | | Neutral | $185.00 -> $150.00 | High | |
BIIB Biogen | 10/28/2021 | Target Lowered by | Cantor Fitzgerald | Analyst Alethia Young | Neutral | $316.00 -> $259.00 | Medium | |
QURE uniQure | 10/26/2021 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | | Medium | |
ETNB 89bio | 10/26/2021 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $58.00 -> $49.00 | High | |
OPA Magnum Opus Acquisition | 10/21/2021 | Initiated by | Cantor Fitzgerald | | Overweight | $10.00 | Low | |
PRQR ProQR Therapeutics | 10/18/2021 | Reiterated by | Cantor Fitzgerald | Analyst B. Cheng | Overweight | | Low | |
ORTX Orchard Therapeutics | 10/18/2021 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight | | Medium | |
KDNY Chinook Therapeutics | 10/18/2021 | Reiterated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | Medium | |
HARP Harpoon Therapeutics | 10/18/2021 | Reiterated by | Cantor Fitzgerald | Analyst B. Cheng | Overweight | | Low | |
GOSS Gossamer Bio | 10/18/2021 | Reiterated by | Cantor Fitzgerald | Analyst B. Cheng | Overweight | | Low | |
FMTX Forma Therapeutics | 10/18/2021 | Reiterated by | Cantor Fitzgerald | Analyst A. Young | Overweight | | High | |
ETNB 89bio | 10/18/2021 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | | Low | |